不同生活方式干预对脂肪库动员的影响:CENTRAL磁共振成像随机对照试验
该18个月随机对照试验纳入278名腹型肥胖或血脂异常久坐成人,比较等热量低脂或地中海/低碳水饮食加核桃并联合或不联合中强度运动对全身脂肪分布的影响。结果显示运动独立降低内脏脂肪,地中海/低碳水饮食更优降低肝内、心包及胰腺脂肪,不同脂肪库反应及与心血管代谢指标关联各异。
要点
- 运动独立于体重减轻显著降低内脏脂肪,地中海/低碳水饮食更优降低肝内、心包和胰腺脂肪。
- 内脏脂肪和肝内脂肪减少独立关联血脂改善,深层皮下脂肪减少关联胰岛素敏感性改善。
- 不同脂肪库对生活方式干预反应不同,减重程度不能充分反映脂肪分布获益。
核心结论
- 中度体重减轻不足以反映生活方式对致动脉粥样硬化和致糖尿病脂肪库的显著影响。
- 地中海/低碳水饮食动员特定异位脂肪库,运动对内脏脂肪减少有独立贡献。
- 不同脂肪库反应性各异,且与心血管代谢标志物关联不同。
研究设计与样本
- 18个月随机对照试验,纳入278名腹型肥胖(75%)或血脂异常的久坐成人(年龄48岁,89%男性,BMI 30.8 kg/m2)。
- 随机分为等热量低脂或地中海/低碳水饮食+28克核桃/天,联合或不联合中强度体力活动(80%有氧; supervised/free gym membership)。
- 主要终点为体脂再分布,特定主要终点为内脏脂肪组织;通过磁共振成像追踪不同脂肪库动态。
主要发现
- 86%完成试验且依从性良好;低脂组更多减少报告脂肪摄入(-21.0% vs -11.5%,P<0.001),地中海/低碳水组更多减少报告碳水化合物摄入(-39.5% vs -21.3%,P<0.001)。
- 运动组较非运动组显著增加每周代谢当量(19.0 vs 2.1,P=0.009);最终中度体重减轻无差异,但运动减轻腰围反弹,地中海/低碳水+运动组效果最大(P<0.05)。
- 内脏脂肪(-22%)、肝内脂肪(-29%)和心包内脂肪(-11%)下降高于胰腺和股骨肌间脂肪(1%至2%)损失。
- 独立于体重减轻,运动+任一饮食较无运动显著更大程度降低内脏脂肪(平均差值-6.67cm2;95%CI -14.8至-0.45)。
- 地中海/低碳水饮食在降低肝内、心包内和胰腺脂肪方面优于低脂饮食(P均<0.05);肾窦和股骨肌间脂肪仅由体重减轻本身改变。
关键数值与推荐
- 内脏脂肪减少或肝内脂肪减少独立关联血脂谱改善;深层皮下脂肪减少关联胰岛素敏感性改善;浅层皮下脂肪减少保持中性,除与瘦素降低相关。
临床怎么用
- 对腹型肥胖或血脂异常患者,运动应作为独立于饮食的干预以降低内脏脂肪。
- 地中海/低碳水饮食可优先考虑用于降低肝内、心包和胰腺等异位脂肪。
- 评估生活方式干预效果时需关注脂肪分布变化,而非仅依赖体重减轻。
局限性
- 研究对象以男性为主(89%),结果外推需谨慎。
- 试验在提供监测午餐的孤立工作场所进行,依从性可能高于日常环境。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to assess whether distinct lifestyle strategies can differentially affect specific body adipose depots. METHODS: We performed an 18-month randomized controlled trial among 278 sedentary adults with abdominal obesity (75%) or dyslipidemia in an isolated workplace with a monitored provided lunch. Participants were randomized to isocaloric low-fat or Mediterranean/low-carbohydrate (MED/LC) diet+28 g walnuts/day with/without added moderate physical activity (PA; 80% aerobic; supervised/free gym membership). Overall primary outcome was body fat redistribution, and the main specific end point was visceral adipose tissue (VAT). We further followed the dynamics of different fat depots (deep and superficial subcutaneous, liver, pericardial, muscle, pancreas, and renal sinus) by magnetic resonance imaging. RESULTS: Of 278 participants (age, 48 years, 89% men, body mass index, 30.8 kg/m2), 86% completed the trial with good adherence. The low-fat group preferentially decreased reported fat intake (-21.0% versus -11.5% for the MED/LC; P<0.001), and the MED/LC group decreased reported carbohydrates intake (-39.5% versus -21.3% for the low-fat group; P<0.001). The PA+ groups significantly increased the metabolic equivalents per week versus the PA- groups (19.0 versus 2.1; P=0.009). Whereas final moderate weight loss was indifferent, exercise attenuated the waist circumference rebound with the greatest effect in the MED/LCPA+ group (P<0.05). VAT (-22%), intrahepatic (-29%), and intrapericardial (-11%) fats declines were higher than pancreatic and femur intermuscular fats (1% to 2%) loss. Independent of weight loss, PA+ with either diet had a significantly greater effect on decreasing VAT (mean of difference, -6.67cm2; 95% confidence interval, -14.8 to -0.45) compared with PA-. The MED/LC diet was superior to the low-fat diet in decreasing intrahepatic, intrapericardial, and pancreatic fats (P<0.05 for all). In contrast, renal sinus and femoral intermuscular fats were not differentially altered by lifestyle interventions but by weight loss per se. In multivariate models further adjusted for weight loss, losing VAT or intrahepatic fat was independently associated with improved lipid profile, losing deep subcutaneous adipose tissue with improved insulin sensitivity, and losing superficial subcutaneous adipose tissue remained neutral except for an association with decreased leptin. CONCLUSIONS: Moderate weight loss alone inadequately reflects the significant lifestyle effects on atherogenic and diabetogenic fat depots. The MED/LC diet mobilizes specific ectopic fat depots, and exercise has an independent contribution to VAT loss. Fat depots exhibit diverse responsiveness and are differentially related to cardiometabolic markers. Distinct lifestyle protocols may uniquely induce fat mobilization from specific anatomic sites. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01530724.
引用
- Gepner Y, Shelef I, Schwarzfuchs D, et al. Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools: CENTRAL Magnetic Resonance Imaging Randomized Controlled Trial. Circulation. 2017. PMID: 29142011. doi:10.1161/CIRCULATIONAHA.117.030501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。